Marker
Predicts Aggressive Prostate Cancer Prostate cancer researchers identified a group of genes that regulates and controls normal prostate development.
Mi - Prostate Score, or MiPS, was significantly more accurate than PSA alone for predicting cancer as well as
predicting aggressive prostate cancer that is likely to grow and spread quickly.
Not exact matches
LONDON, Oct 9 - Scientists have found two distinct genetic «signatures» for
prostate cancer that may help doctors
predict which patients have
aggressive tumours, and designed experimental blood tests to read those genetic signs like barcodes.
Prostate cancer is has a genetic component but it has until now been impossible to understand how aggressive the cancer might be Now a new multi-national study has discovered the basis of a simple blood test which can predict whether a man is susceptible to aggressive prostate
Prostate cancer is has a genetic component but it has until now been impossible to understand how
aggressive the
cancer might be Now a new multi-national study has discovered the basis of a simple blood test which can
predict whether a man is susceptible to
aggressive prostateprostate cancer.
Scientists are reporting a test which can
predict which patients are most at risk from
aggressive prostate cancer, and whether they suffer an increased chance of treatment failure.
«Scientists report genetic test to help
predict men at most risk from
aggressive prostate cancer.»
His laboratory is investigating genetic markers that
predict development of
aggressive prostate and breast
cancers, and nanotechnology - based therapies for breast and
prostate cancers.
I think we all agree that we over treat
prostate cancer in this country compared to what you see in Europe with similar outcomes and so but I think this is where the human or the Cancer Genome Project or at least better biomarkers for looking at mutations that we already know occur in these diseases I think hopefully within the next few years every single patient who is diagnosed with prostate cancer those biopsies will be characterized and then the patients followed, hopefully watchful waiting and we'll ultimately get a correlation between what mutational events predict a rather dormant disease as opposed to a very aggressive di
cancer in this country compared to what you see in Europe with similar outcomes and so but I think this is where the human or the
Cancer Genome Project or at least better biomarkers for looking at mutations that we already know occur in these diseases I think hopefully within the next few years every single patient who is diagnosed with prostate cancer those biopsies will be characterized and then the patients followed, hopefully watchful waiting and we'll ultimately get a correlation between what mutational events predict a rather dormant disease as opposed to a very aggressive di
Cancer Genome Project or at least better biomarkers for looking at mutations that we already know occur in these diseases I think hopefully within the next few years every single patient who is diagnosed with
prostate cancer those biopsies will be characterized and then the patients followed, hopefully watchful waiting and we'll ultimately get a correlation between what mutational events predict a rather dormant disease as opposed to a very aggressive di
cancer those biopsies will be characterized and then the patients followed, hopefully watchful waiting and we'll ultimately get a correlation between what mutational events
predict a rather dormant disease as opposed to a very
aggressive disease.